Cooley advised Avant on the deal. Avant, a credit-first financial technology company, announced that it secured $250 million of corporate debt and redeemable preferred equity from...
Avant’s $250 Million Financing from Ares
Poseida Therapeutics’ Collaboration and License Agreement With Roche
Cooley advised Poseida Therapeutics on the deal. Poseida Therapeutics, a clinical-stage biopharmaceutical company, announced its strategic collaboration and license agreement with Roche. The agreement will leverage Poseida’s...
Sweetgreen’s $364 Million Initial Public Offering
Latham & Watkins represented the underwriters in the offering while Cooley LLP represented sweetgreen. Sweetgreen, Inc. executed its initial public offering of Class A common stock at...
Lumentum’s $918 Million Acquisition of NeoPhotonics
Cooley LLP advised NeoPhotonics on the deal. NeoPhotonics, a developer and manufacturer of optoelectronic solutions, announced its agreement to sell to Lumentum for $918 million. The acquisition...
The Honest Company’s $475 Million IPO
Cooley LLP advised The Honest Company on the deal. The Honest Company, a consumer goods company founded by actress Jessica Alba, announced its $475 million initial public...